PATENT CLAIM ANALYSIS

Application Number: 16173914
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "507000"]

Abstract:
Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R 1 , R 2  and R 3  are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Claim (Index 11):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof wherein R 4  is selected from the group consisting of:

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.3617
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13806339', '12643229', '16030729', '15991703', '15991747']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8006655269484062
- 35 USC 102 Novelty (BERT): 0.5477618623477254
- Combined Prediction Score: 0.7753751604883381
- Mean Citation Score: 366.085984
- Max Citation Score: 395.54996
- Similarity Product: 311.682188260622

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test